8VC, established in 1969 and headquartered in San Francisco, is a venture capital firm that invests in early-stage companies across various sectors, with a focus on enabling industry transformation. The firm, which is a Registered Investment Adviser, partners with founders to develop transformational technologies, targeting sectors such as healthcare, logistics, biology, IT infrastructure, and government & defense. 8VC aims to create long-term economic and societal value through its investments, promoting innovation and global prosperity.
Glimpse is a company that collaborates with brands to integrate their products into luxury short-term rentals, serving as a unique sales and acquisition channel. Established in 2020 by Kushal Negi, Akash Raju, and Anuj Mehta, the firm is based in New York. In addition to its focus on product placement, Glimpse develops artificial intelligence automation tools aimed at enhancing the efficiency of consumer packaged goods (CPG) sales and operations teams. These tools automate various processes, including purchase order data entry, inventory management, and buyer engagement, while also streamlining communication and order management. By leveraging AI, Glimpse helps businesses identify issues such as stock shortages and provides key insights from retail data, ultimately improving operational efficiency and decision-making.
Lumber
Series A in 2025
Lumber is a technology company specializing in construction workforce management. It offers an automated platform that streamlines payroll, time tracking, accounts payable, compliance, and onboarding processes for construction businesses. The platform leverages artificial intelligence and automation to provide contractors with enhanced control over their operations and simplified finance management.
Patlytics
Series A in 2025
Patlytics is a developer of an artificial intelligence-powered platform that streamlines the entire patent lifecycle. The platform provides a range of features, including patent drafting, prosecution, litigation readiness, competitive landscape analysis, and real-time alerts and reports. By leveraging advanced technology, Patlytics enhances patent workflow efficiency, helping businesses to effectively manage their intellectual property portfolios and maintain a competitive edge in the market.
Latent Labs
Series A in 2025
Latent Labs is a pioneering AI laboratory specializing in programmable biology. The company develops advanced generative AI models that capture the fundamental principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.
Coram AI
Series A in 2025
Coram AI develops video intelligence systems aimed at enhancing business operations. The company offers a platform that transforms standard cameras into intelligent systems, providing valuable insights into various aspects of daily operations, including safety and security. By leveraging this technology, businesses of all sizes can gain fresh perspectives on their processes and make informed decisions that drive operational improvements. Coram AI's innovative approach allows clients to utilize their existing camera infrastructure more effectively, turning passive video recording into an active tool for operational enhancement.
Overland AI
Series A in 2025
Overland AI specializes in the development of autonomous navigation technology tailored for off-road vehicles. The company focuses on creating artificial intelligence-based solutions that enhance off-road autonomy, particularly for mission-critical sectors such as defense and national security. By utilizing machine learning and robotic systems, Overland AI provides modular software designed to facilitate the autonomous navigation of unimproved roads and rugged terrain. This technology enables clients to operate vehicles independently in challenging environments like mines, construction sites, and disaster zones, addressing the need for reliable transportation solutions in demanding conditions.
Reveal Technology
Series A in 2024
Reveal Technology is a visual analytics and edge artificial intelligence (AI) company.
Seen Health
Series A in 2024
Seen Health is a healthcare firm focused on empowering older adults to age with dignity within their communities. The company specializes in culturally-informed, technology-enabled healthcare services that combine medical care and social support. Through its Program of All-Inclusive Care for the Elderly (PACE) model, Seen Health aims to provide quality care tailored to the unique needs of older adults, facilitating a holistic approach to health and well-being.
Even
Series A in 2024
Even is a health tech company that collaborates with leading hospitals to provide comprehensive healthcare services through a subscription model. Its offerings include unlimited diagnostics, consultations, and hospitalization coverage valued at up to 50 lakh. The company simplifies the reimbursement process by directly transferring funds to partner hospitals, ensuring a seamless experience for members. By charging a recurring monthly fee, Even aims to address critical long-term health needs for individuals, making healthcare more accessible and manageable.
Numeric
Series A in 2024
Companies rely on Numeric to ensure their financial data is accurate, automate the month-end close, and generate real-time insights. Rated 4.9 / 5 on G2
Amber Therapeutics
Series A in 2024
Amber Therapeutics is a biotechnology company that specializes in developing advanced bioelectrical therapies aimed at treating functional disorders of the peripheral nervous system. The company creates a bioelectronic platform that delivers closed-loop bioelectrical treatments, which can sense and adapt to the patient's needs while also providing stimulation. By focusing on conditions such as mixed urinary incontinence, Amber Therapeutics seeks to enhance clinical efficacy and patient outcomes through innovative approaches that emphasize the peripheral nervous system rather than the central nervous system. Its technology has the potential to significantly improve treatment methods and overall patient care in targeted disease areas.
iCOMAT
Series A in 2024
iCOMAT is a developer of advanced automated composite manufacturing technology, primarily targeting the aerospace, automotive, and marine sectors. The company has introduced Rapid Tow Shearing (RTS), a groundbreaking process that allows for defect-free fiber steering in composite materials. This innovative approach enables the placement of carbon fiber tapes along curved paths, resulting in lighter, stronger, and more cost-effective products. By optimizing the mechanical properties of composites, iCOMAT's technology improves structural performance while significantly reducing the use of raw materials and overall production costs. As a spin-out from the University of Bristol, iCOMAT aims to revolutionize transport and manufacturing processes by providing solutions that enhance product performance and efficiency across multiple markets.
Luminate Medical
Venture Round in 2024
Luminate Medical is focused on developing a medical device aimed at preventing hair loss during chemotherapy. Recognizing the significance of hair for personal identity and self-esteem, the company has created a portable and comfortable wearable system. This innovative device allows patients to manage and mitigate the side effects associated with cancer treatment, thereby helping them maintain their confidence and dignity during a challenging time. By leveraging advances in medical technology, Luminate Medical is dedicated to enhancing the quality of life for individuals undergoing chemotherapy.
Latus Bio
Series A in 2024
Latus Bio is a biotechnology company dedicated to developing innovative gene therapies for neurological diseases. It specializes in precision delivery using proprietary adeno-associated virus (AAV) capsids derived from non-human primates, enabling targeted and efficient gene transfer to specific cells in the central nervous system. Latus aims to enhance the safety and manufacturability of its therapies by administering low doses of its product candidates.
Amae Health
Series A in 2024
Amae Health is a mental wellness clinic that offers specialized care for individuals with severe mental illness. The clinic focuses on understanding the unique needs of its patients and provides tailored treatment solutions that integrate behavioral medicine, primary care, and social health. By addressing these diverse aspects of care, Amae Health aims to help patients and their families stabilize and thrive, while also working to prevent future adverse health events. Through its comprehensive approach, the clinic seeks to enhance health outcomes for those it serves.
Edia Learning
Series A in 2024
Edia is an EdTech platform for 6-12 Math that ensures superior state test outcomes.
Campus
Series A in 2024
Campus is an accredited online community college that focuses on providing accessible educational opportunities to students across the country. It offers a range of live online and in-person associate degrees and certificate programs, emphasizing student success and support. By leveraging an online educational platform, Campus aims to facilitate a flexible learning environment that meets the diverse needs of its student population.
Lightbeam.ai
Series A in 2024
LightBeam.ai is a leader in data security and privacy automation, dedicated to helping organizations manage and access sensitive information securely. The company offers a platform that utilizes advanced data management, entity linkage techniques, and deep learning to analyze documents, speech, and natural language processing at scale. This technology integrates seamlessly with various data sources across industries, enabling clients to derive actionable insights while maintaining data privacy and confidentiality. By providing a unified control tower for data cataloging, access, and sharing, LightBeam empowers privacy and compliance executives to ensure continuous compliance, while information security professionals can trust that sensitive data is accessed and utilized securely.
Harbor Health
Series A in 2024
Harbor Health is a multi-specialty clinic group based in Austin, Texas, founded in 2022. The organization focuses on delivering personalized, patient-centered healthcare by utilizing technology to enhance the patient experience. Harbor Health offers a collaborative approach to healthcare, working closely with individuals to understand their health goals and providing access to specialists when necessary. The clinic provides a variety of services, including primary care, chronic disease management, behavioral health, and overall wellness. Patients benefit from same-day and virtual appointment options, as well as conveniently located clinics, ensuring that healthcare is accessible and responsive to their needs.
Cambium
Series A in 2023
Cambium is a company focused on developing biomaterials for various sectors, including defense, aerospace, and renewable energy. Established in 2019 and located in Berkeley, California, it specializes in advanced materials research and development. The company utilizes a combination of synthetic biology, materials science, and artificial intelligence to enhance material performance and sustainability. Cambium's approach involves vertically integrated innovation, ranging from computational material discovery to the production of advanced composites within the United States. By leveraging cutting-edge advancements across multiple scientific disciplines, Cambium aims to improve existing products and facilitate the creation of next-generation materials.
Samara
Series A in 2023
Samara is a home services company that specializes in home renovation, interior design, and architectural services. The firm operates a design studio aimed at enhancing living spaces by offering customized solutions for clients. Samara focuses on building homes and creating tailored backyards that accommodate studios and bedrooms, allowing clients to fully personalize their residences. Through its various services, the company seeks to improve the quality of living for its customers by transforming their homes into functional and aesthetically pleasing environments.
Saronic Technologies
Series A in 2023
Saronic Technologies specializes in the design and manufacture of advanced unmanned surface vehicles (USVs). These vehicles are equipped with cutting-edge hardware, software, and artificial intelligence, creating a scalable and integrated platform for enhancing maritime security and domain awareness. Tailored for defense and surveillance applications, Saronic's products offer comprehensive operational capabilities to naval and maritime forces.
Reserv
Series A in 2023
Reserv is a digital claims third-party administrator focused on optimizing property and casualty (P&C) claims through the use of modern systems. The company offers a range of solution-first products and services designed to enhance the entire claims ecosystem. By ensuring compliance with insurance carriers, Reserv serves as an incubator for testing innovative technologies and AI services, aimed at improving claims efficiency and outcomes. The company addresses critical resource challenges faced in the claims process, positioning itself as a key player in claims innovation.
Endear Health
Series A in 2023
Endear Health is a technology company focused on addressing the needs of an aging population. It has developed an online healthcare platform that serves as a single access point for Medicare-eligible individuals, enabling them to efficiently manage their health and benefits. The platform offers user-friendly tools that help seniors collect and organize important health information, allowing them to navigate healthcare challenges and take control of their well-being. Through its innovative approach, Endear Health aims to empower older adults in their healthcare journeys.
Vital Bio
Venture Round in 2023
Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.
DataHub
Series A in 2023
DataHub Core is the #1 open source platform with a uniquely scalable and extensible metadata graph supporting manual and automated data management. DataHub Cloud is an enterprise-ready SaaS solution providing a fully-managed service of DataHub Core with additional AI-powered capabilities in discovery, observability, and governance to accelerate production-readiness of AI and data assets.
Myeloid Therapeutics
Series A in 2023
Myeloid Therapeutics is an immunology company dedicated to harnessing myeloid cells for the treatment of cancer and other diseases. The company employs its ATAK platform technology, which focuses on reprogramming innate immune cells to enhance their ability to target and eliminate cancerous cells. This platform is designed to be versatile and scalable, allowing for the development of various treatment modalities across multiple disease areas. Currently, Myeloid Therapeutics is advancing a cell therapy program aimed at T cell lymphoma, as well as a primed monocyte approach for treating glioblastoma. Through its innovative technology, the company seeks to overcome the limitations of existing cell therapies and improve patient outcomes.
Empassion
Venture Round in 2023
Empassion Health is a provider of comprehensive, community-based care services for patients with advanced illnesses, founded in 2022. The company focuses on serving individuals facing serious health challenges by offering essential tools for managing their care throughout the continuum. Services include patient enrollment, care management, and care coordination, along with primary care visits, urgent care, goals planning, and social and spiritual care planning. Empassion Health aims to help patients optimize their daily lives while preserving their well-being and independence at home.
Chaos
Series A in 2023
Chaos Industries is a technology company specializing in next-generation solutions for defense and critical industries. The company is dedicated to enhancing sensing, detection, and communication capabilities through the use of Coherent Distributed Networks (CDN). Its focus on detection and radar services supports the development of advanced defense products, allowing clients to access high-quality services tailored to their needs.
Atomic AI
Series A in 2023
Atomic AI is focused on advancing RNA drug discovery through the integration of machine learning and structural biology. The company operates a content intelligence platform that facilitates the rational design of new molecules and medicines. By leveraging engagement data from clients' analytics, Atomic AI gathers insights to create predictive reports on various topics, including optimal publishing times and distribution channels. This approach equips users with innovative strategies to develop treatments or cures for diseases by specifically targeting RNA structures.
Oula Health
Series A in 2023
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.
Mantra Bio
Series A in 2023
Mantra Bio, Inc. is a biotechnology company focused on developing targeted therapeutics through its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). Founded in 2016 and based in San Francisco, California, the company utilizes its REVEAL platform, which combines computational biology, wet lab techniques, and automation. This innovative approach allows for the design, testing, and optimization of TEVs tailored for specific therapeutic applications across diverse tissue and cellular targets. In addition to its engineering capabilities, Mantra Bio has established a scalable biomanufacturing process to ensure that these novel therapeutics can be produced reproducibly and with high purity, aiming to address intractable diseases effectively.
Second Front
Series A in 2022
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.
Telegraph
Series A in 2022
Telegraph is a technology company founded in 2020 and headquartered in Chicago, Illinois, that focuses on transforming the freight rail industry through its innovative cloud-based platform. The company simplifies complex workflows and enhances collaboration among railroads, shippers, and third-party logistics providers, thereby improving visibility and insights into rail operations. By employing advanced technology, Telegraph aims to create a more sustainable and efficient supply chain, facilitating seamless logistics and streamlined operations across the freight ecosystem.
SURGE Therapeutics
Series A in 2022
SURGE Therapeutics is dedicated to enhancing cancer patient survival through innovative approaches in immunotherapy. The company has developed a proprietary injectable biodegradable hydrogel designed for the prolonged and localized release of cancer immunotherapy following surgical tumor resection. By targeting the administration of treatment to specific areas at the optimal time, SURGE Therapeutics aims to improve the effectiveness of immunotherapy, allowing for both intravenous and intratumoral injections. This technology seeks to disrupt traditional cancer treatment paradigms and provide better outcomes for patients.
Invisible AI
Series A in 2022
Invisible AI Inc. is a technology company specializing in artificial intelligence-based camera systems designed for logistics and manufacturing facilities. Founded in 2018 and headquartered in San Francisco, the company offers a no-code, edge-based visual intelligence platform that enhances quality, productivity, and safety in manufacturing environments. Its low-cost, low-bandwidth cameras are strategically deployed at workstations to monitor real-time human motion, enabling clients to optimize workflow and reduce costs associated with manual assembly errors. The accompanying web dashboard provides clients with visibility and built-in intelligence to protect data while facilitating the integration, tracking, and analysis of operational practices. This comprehensive system helps clients ensure that processes are executed accurately and safely, ultimately improving overall efficiency.
Jacobi
Series A in 2022
Jacobi, Inc. is a technology company that has developed a platform for investment managers to design, analyze, and visualize multi-asset portfolios. Founded in 2014 and headquartered in San Francisco, California, with additional offices in Brisbane, Australia, and London, United Kingdom, Jacobi provides customizable tools that streamline investment processes, allowing users to aggregate portfolios, analyze allocations, and assess associated risks and returns. The platform facilitates deeper engagement between investment managers and clients by transforming complex financial data into intuitive visualizations and interactive dashboards. Additionally, Jacobi offers software development kits to further enhance the capabilities of its platform, promoting better decision-making and improved investment strategies.
Opto Investments
Series A in 2022
Opto Investments, founded in 2020 and based in New York, is a private equity firm that provides independent investment advisors with a comprehensive platform for accessing private market investments. The firm connects advisors to top-performing managers and offers a full suite of alternative asset tools, along with expert insights, to enhance revenue opportunities. By facilitating access to private investment options, Opto Investments aims to help clients build long-term wealth.
Rephrase.ai
Series A in 2022
Rephrase.ai specializes in an AI-powered video creation technology that transforms text into animated videos featuring realistic facial representations of individuals. This innovative approach employs generative AI to analyze and learn the facial features of specific people in relation to spoken audio, allowing the system to create photorealistic visuals for any new text or audio input. The platform serves a variety of applications, enabling clients to produce training videos, personalize sales presentations, animate characters in augmented and virtual reality, and provide a visual identity for digital assistants. Through its advanced technology, Rephrase.ai enhances the way organizations communicate and engage with their audiences.
Harbor Health
Series A in 2022
Harbor Health is a multi-specialty clinic group based in Austin, Texas, founded in 2022. The organization focuses on delivering personalized, patient-centered healthcare by utilizing technology to enhance the patient experience. Harbor Health offers a collaborative approach to healthcare, working closely with individuals to understand their health goals and providing access to specialists when necessary. The clinic provides a variety of services, including primary care, chronic disease management, behavioral health, and overall wellness. Patients benefit from same-day and virtual appointment options, as well as conveniently located clinics, ensuring that healthcare is accessible and responsive to their needs.
Photys Therapeutics
Series A in 2022
Photys Therapeutics is a biopharmaceutical company focused on developing bifunctional small molecules that provide precise control over protein post-translational modifications. This innovative platform allows for the restoration of protein function, repair of cellular signaling pathways, and enhancement of the body's natural disease-fighting abilities. Co-founded by prominent chemist Amit Choudhary from the Broad Institute and the Longwood Fund, Photys is supported by a scientific advisory board that includes renowned experts from institutions such as MIT, Salk Institute, and Berkeley. The company's unique approach aims to advance therapeutic options in the healthcare industry, particularly by targeting kinases and potentially phosphatases, to address various diseases effectively.
KeyCare
Series A in 2022
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.
Cartography Biosciences
Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company has created a platform-based cell therapy that utilizes single-cell analysis to identify innovative CAR-T targets. This approach allows for the design of cancer immunotherapies tailored to the safest and most effective targets. By combining molecular biology and computational methods, Cartography enables clients to advance their studies in the development of these targeted treatments, aiming to improve outcomes for cancer patients.
Fruitful
Series A in 2022
Fruitful is a financial wellness platform aimed at empowering individuals to manage their finances more effectively. The platform provides members with personalized financial advice from qualified specialists, hands-on investment management, and access to high-yield savings options. It also simplifies the banking experience by offering tools that integrate various third-party apps, bank accounts, and financial services into a single dashboard. This subscription-based model allows users to benefit from tailored banking services while enhancing their financial understanding and promoting a secure financial future.
Felux
Series A in 2022
Felux is a business-to-business marketplace and supply chain platform focused on the mining industry. The company provides a variety of services, including procurement solutions and supply chain management, facilitating the buying and selling of industrial products. Its platform enables users to source, procure, ship, finance, and analyze transactions related to steel, all in one location. This comprehensive approach allows suppliers to digitize their operations and manage their selling and distribution processes efficiently.
Seaplane IO
Series A in 2022
Seaplane IO Inc. is a technology company based in Mountain View, California, focused on developing a serverless cloud software system tailored for modern enterprises. Founded in 2020, the company enables developers to create and scale applications efficiently without the complexities of managing cloud infrastructure. Its platform supports both on-premises and cloud server deployments, allowing for deployment from any location worldwide. By facilitating multi-cloud and edge computing, Seaplane IO provides essential APIs, services, and support, empowering software developers to deliver optimized applications to users globally.
Candid Health
Series A in 2022
Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.
Fieldguide
Series A in 2022
Fieldguide, Inc. is an enterprise software company that provides an automation and collaboration platform specifically designed for audit and advisory firms. Founded in 2020 and based in Sacramento, California, the company offers a suite of workflow software features, including secure data requests, work plan management, reporting automation, and resource planning. The platform utilizes artificial intelligence to standardize templates and facilitate drag-and-drop report creation, helping firms streamline their project lifecycle. By enhancing productivity and client satisfaction, Fieldguide enables firms to improve their margins and foster stronger client relationships. The company is supported by notable venture capital investors, including 8VC, Floodgate, and Y Combinator.
OpenComp
Series A in 2022
OpenComp provides a compensation planning tool that helps high-growth companies make informed decisions regarding their compensation practices. Founded in 2021 by Thanh Nguyen and Nancy Connery, who were part of Salesforce's founding HR team, OpenComp serves over 2,000 organizations, including notable names like Calm, Discord, and Reddit. The platform enables companies to attract and retain top talent through fair and consistent compensation strategies. It also offers features that allow organizations to analyze the impact of compensation changes on their financials while providing benchmarking data by gender and ethnicity. OpenComp offers its services for free to companies with up to 50 employees, with tiered pricing available for larger organizations based on their specific needs. The company has secured $24 million in venture capital from notable investors, including J.P. Morgan and Marc Benioff's TIME Ventures.
Standard Metrics
Series A in 2022
Standard Metrics is an automated financial platform that streamlines data management for investors and startups. By eliminating data silos commonly found in spreadsheets and outdated applications, it provides a centralized system for accessing essential financial metrics and investment information. The platform enables real-time engagement between investors and founders, fostering transparency and facilitating informed decision-making. With automated data collection and comprehensive portfolio management services, Standard Metrics empowers startups to analyze their performance effectively, ultimately aiding in strategic scaling and maximizing returns for investors.
180° Insurance
Series A in 2022
180° is an InsurTech company that provides insurance services. With a focus on the B2B2C model, the company builds insurance and assistance products with technology that are connected to customers' daily lives in a simple and digital way. 180° was founded in 2020 and is headquartered in Sao Paulo, Brazil.
Cellino
Series A in 2022
Cellino is focused on creating an automated biomanufacturing system for personalized cell therapies, with the aim of making these treatments widely accessible. The company leverages an AI-guided laser editing platform that employs image-guided machine learning and robotics to generate autologous induced pluripotent stem cells (iPSCs) at scale. This innovative approach is designed to facilitate the development of potentially curative therapies for chronic degenerative diseases, such as vision loss and Parkinson's disease. By streamlining the process of cell therapy production, Cellino aims to enhance the availability of life-saving medicines for patients around the world.
Rocketlane
Series A in 2022
Rocketlane is a developer of a customer onboarding platform that enhances the efficiency of implementation and onboarding projects for professional services teams. The platform facilitates collaborative project execution, time tracking, AI-enabled resource management, and project accounting, which improves communication and visibility throughout customer projects. By streamlining workflows and providing a consistent execution strategy, Rocketlane enables businesses to deliver an exceptional onboarding experience, ensuring that customers realize value quickly and effectively. Its clientele includes notable companies such as Clari, Drift, Icertis, Showpad, Uniphore, and Vidyard, among others, reflecting its global reach and impact in enhancing project governance and collaboration.
Ritten
Venture Round in 2022
Ritten operates an electronic medical records platform designed specifically for addiction treatment providers to enhance the quality of care for their patients. The platform facilitates personalized, data-informed care by offering customized workflow configurations that support the consistent and compliant delivery of complex treatment. It enables clinicians and administrators to maintain comprehensive patient records that encompass all aspects of a patient's care, including clinical notes, medications, and treatment plans. This approach allows healthcare professionals to provide tailored care while effectively tracking patient progress and needs.
Software.com
Series A in 2021
Software.com is an online retailer of software solutions based in Manhattan Beach, California. As a subsidiary of Internet Real Estate Group, LLC, the company focuses on enhancing software development by collecting and analyzing data across the development stack. This approach aims to assist developers and teams in learning from their experiences, thereby increasing productivity and improving coding practices.
Petra
Series A in 2021
Petra is a robotics company specializing in underground utility solutions. The firm has developed advanced tunneling robots designed to efficiently and safely bore utility conduits through various geological conditions, including high-grade hard rock. By enabling the undergrounding of critical utilities, Petra provides a practical and cost-effective means to construct small-diameter infrastructure, particularly in disaster-prone areas. Their technology addresses the challenges of traditional tunneling methods, making it feasible to install essential utilities in previously inaccessible locations.
Elegen
Series A in 2021
Elegen is a biotechnology company founded in 2017, focused on developing microfluidic technology to advance synthetic biology. Led by Dr. Matthew Hill, Elegen aims to revolutionize the field by engineering entire genomes and creating innovative DNA synthesizers. Their technology is designed to enhance the speed and efficiency of DNA sequence testing, thereby facilitating significant progress in biomedical research and healthcare applications. Through these efforts, Elegen seeks to contribute to the rapid development of solutions that address various challenges in the life sciences sector.
Surglogs
Series A in 2021
Surglogs INC. is a software development company focused on enhancing the administrative efficiency of ambulatory surgery centers and healthcare facilities. Founded in 2015 and based in San Diego, California, Surglogs provides a comprehensive digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application. The software organizes compliance-related documents for accreditation, facilitates device authorization, and automates daily checks and notifications. Additionally, it offers customizable solutions and electronic report export services, streamlining the management of logbooks, medications, supplies, staff training, and drills. By serving healthcare professionals, including doctors, nurses, and administrators, Surglogs aims to simplify regulatory compliance and improve operational workflows within healthcare organizations.
Quince
Series A in 2021
Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.
Spartan Radar
Series A in 2021
Spartan Radar specializes in advanced radar technology that creates high-resolution real-time imagery, utilizing proprietary software algorithms that incorporate machine learning and edge-processing. By mimicking human sensory perception, Spartan's solutions enhance the performance of existing advanced driver-assistance systems (ADAS) by improving resolution, response time, and range while maintaining low computational demands. The company's expertise in signal processing, developed through years of experience in the aerospace and automotive sectors, enables it to offer cost-effective sensing solutions. Spartan's platform is applicable across various industries, including drone and automotive applications, positioning the company as a leader in innovative radar technology.
Better Health
Series A in 2021
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.
Mindbloom
Series A in 2021
Mindbloom, established in 2008, is a Seattle-based mental health and wellbeing company. It offers at-home, clinician-prescribed psychedelic therapies, specifically ketamine for anxiety and depression, facilitated by expert guides. The platform connects users with licensed clinicians who assess their health history and provide personalized care. Mindbloom's approach combines behavioral science, personalized rich media, and engaging social gaming techniques, making the process of mental health improvement fun, simple, and effective. The company has served over 30,000 users and has enterprise customers such as Aetna, with research partnerships including UC Santa Barbara and Stanford University.
Esper
Series A in 2021
Esper is a developer of a policy collaboration platform that assists government agencies in managing public policy effectively. The company's software enables officials to integrate and transform policy data into actionable insights, promoting transparent and data-driven decision-making. By streamlining internal workflows, Esper helps create a comprehensive infrastructure that supports the entire policymaking lifecycle. The company has established partnerships with various government entities, including the New York City Police Department, Washington Department of Health, and California State Treasurer’s Office. With a workforce of over 30 employees, Esper has successfully secured over $14 million in funding to enhance its offerings and expand its reach in the public sector.
Formlogic
Series A in 2021
Formlogic is a provider of autonomous manufacturing technology focused on delivering precision components for the space and frontier industries. The company aims to revolutionize part production by addressing issues within the domestic supply chain. Its advanced technology enhances the capabilities of workers, allowing novices to achieve expert-level tolerances while increasing productivity for experienced operators. Formlogic offers rapid turnaround times, with production orders completed in weeks, and provides real-time order status updates. This approach enables industries to obtain custom machined components with close tolerances at scale, improving overall efficiency and customer experience.
Appia Bio
Series A in 2021
Appia Bio is a biotechnology company dedicated to the research and development of allogeneic cell therapies that can be readily available for patients. The company focuses on creating engineered cell therapies for various medical conditions using its innovative ACUA technology platform. This platform utilizes the biology of lymphocyte development along with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to produce CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes derived from hematopoietic stem cells. By maturing and scaling healthy stem cells into these therapies, Appia Bio aims to provide safe and targeted cancer treatments, thereby enhancing accessibility to off-the-shelf cell therapies for physicians and patients alike.
Seed Health
Series A in 2021
Seed Health is a biotechnology company focused on advancing health through innovative applications of microbial sciences. The company develops health supplements that combine probiotics and prebiotics, targeting various aspects of well-being, including digestive health, skin health, heart health, and micronutrient synthesis. By collaborating with academic researchers, Seed Health aims to bring breakthrough discoveries to market, offering consumers live biotherapeutics designed to enhance both human and environmental health.
Polly
Series A in 2021
PollyEx, Inc. operates a loan trading platform focused on the mortgage capital markets, facilitating transactions between buyers and sellers of mortgage loans. Founded in 2017 and based in San Francisco, California, PollyEx enhances loan sale execution through its cloud-based platform, which integrates with buyers and sellers via API, thereby increasing liquidity and automating various functions within capital markets. The platform aims to provide pricing transparency and improve operational efficiency for lenders, enabling them to make informed decisions throughout the lifecycle of a loan.
Polly
Series A in 2021
Polly is an anonymous polling application that allows users to create and share polls on social media platforms like Snapchat and Instagram. The app enables users to formulate questions and attach them to their stories, facilitating honest feedback from friends. By providing a fun and interactive way to gauge opinions, Polly encourages user engagement and fosters social interaction through its uniquely designed features.
Baton
Series A in 2021
Baton Trucking, Inc. is a logistics company based in San Francisco, California, that specializes in enhancing long-haul trucking efficiency through its innovative drop zone network. This network allows for the segmentation of long routes, facilitating the use of specialized vehicles for different sections of the journey. Additionally, Baton provides a real estate infrastructure designed for highway-only autonomous trucks to seamlessly interchange loads with human drivers for final-mile delivery. Incorporated in 2019, the company also operates a technology innovation laboratory that collaborates with Ryder System, focusing on a digital platform that utilizes optimization and artificial intelligence to streamline freight networks and reduce waste in trucking operations.
Elemy
Series A in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in areas such as autism, ADHD, OCD, depression, social anxiety, and bipolar disorder. Launched in April 2020, the company utilizes a technology-driven care model that modernizes traditional healthcare delivery through in-home services. This approach enhances access to care, improves clinical outcomes, and reduces costs. Elemy's platform offers free autism assessments and matches children with therapists to develop individualized treatment plans tailored to their specific needs. The multidisciplinary clinical team implements an integrated treatment model that has demonstrated significant improvements in behavior. Backed by notable venture capital and healthcare investors, Elemy is committed to transforming the landscape of childhood mental health care.
Edgybees
Series A in 2021
Edgybees Ltd. is a technology company based in Palo Alto, California, founded in 2016, that specializes in augmented reality solutions for high-speed applications. Its platform enables real-time, immersive AR experiences for various moving objects, including drones, cars, and wearable devices, by overlaying three-dimensional visuals on live video feeds. This capability is particularly beneficial for sectors such as emergency response, homeland security, real estate, urban planning, and agriculture. The company's offerings include a developer SDK and back-end SaaS services designed to support a wide range of consumer and commercial applications. Edgybees also provides gaming solutions like Droneprix AR and Drone FX, targeting both the entertainment and industrial markets. Co-founded by Menashe Haskin, Adam Kaplan, and Nitay Megides, Edgybees aims to enhance operational effectiveness in military and emergency contexts through its innovative AR technology.
BigHat Biosciences
Series A in 2021
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.
Raydiant
Series A in 2021
Raydiant Inc., established in 2017 and headquartered in San Francisco, specializes in designing, developing, and providing an experience platform that connects employees and customers with brands across various industries such as banking, retail, hospitality, and healthcare. The company's solution comprises kiosks, virtual agents, and multimedia devices for screen management, enabling businesses to create engaging in-store experiences through digital signage. Raydiant works with over 5,000 brands worldwide, including notable clients like Johnson & Johnson and Chick-Fil-A, helping them streamline operations, enhance customer experiences, and drive sales growth.
Myeloid Therapeutics
Series A in 2021
Myeloid Therapeutics is an immunology company dedicated to harnessing myeloid cells for the treatment of cancer and other diseases. The company employs its ATAK platform technology, which focuses on reprogramming innate immune cells to enhance their ability to target and eliminate cancerous cells. This platform is designed to be versatile and scalable, allowing for the development of various treatment modalities across multiple disease areas. Currently, Myeloid Therapeutics is advancing a cell therapy program aimed at T cell lymphoma, as well as a primed monocyte approach for treating glioblastoma. Through its innovative technology, the company seeks to overcome the limitations of existing cell therapies and improve patient outcomes.
Kojo
Series A in 2020
Kojo is a cloud-based construction management software company that provides an all-in-one platform for contractors to manage their material and inventory needs. Founded in 2018 and based in San Francisco, Kojo's system focuses on streamlining materials management and procurement processes, enhancing profitability for construction companies. By integrating various stakeholders, including field teams, procurement, and distributors, Kojo simplifies the supply chain through automation, facilitating the ordering and tracking of materials. This approach enables contractors to ensure timely delivery of materials to job sites, thereby improving operational efficiency.
Cellares
Series A in 2020
Cellares Corporation, founded in 2019 and based in South San Francisco, California, focuses on advancing cell therapy for cancer treatment by addressing the significant manufacturing challenges associated with these therapies. The company has developed the Cell Shuttle, an automated and closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of multiple patient doses, achieving tenfold scalability compared to traditional methods, while also reducing process failure rates by three times and lowering manufacturing costs by up to 70 percent. Cellares aims to make life-saving cell therapies more affordable and widely accessible to patients in need, thereby accelerating the development and availability of these critical treatments.
Twingate
Series A in 2020
Twingate Inc. is a technology company based in Redwood City, California, established in 2018. It specializes in providing secure remote access solutions for organizations, focusing on private applications, data, and environments, whether hosted on-premise or in the cloud. Twingate's platform utilizes a modern zero-trust approach, designed to replace traditional and often insecure VPNs that struggle to support the contemporary needs of remote work and cloud-based resources. The technology features resource-level control, a centralized web-based administration console, split tunneling, and intelligent routing, ensuring that employees can work securely from any location. Twingate aims to enhance security while maintaining usability and ease of deployment, making it a suitable solution for DevOps, IT, and infrastructure teams, as well as end users.
Dren Bio
Series A in 2020
Dren Bio is a biotechnology company that specializes in protein engineering technologies designed to target and deplete pathogenic cells, protein aggregates, and other disease-causing agents. With a focus on hematologic neoplasms, solid cancers, autoimmune disorders, and diseases related to protein aggregation, the company aims to provide innovative solutions for healthcare professionals in their efforts to combat various serious diseases. Operating under a holding company model, Dren Bio develops multiple projects as standalone assets, seeking to create value through its diverse portfolio of biotechnology initiatives.
Sonoma Pharmaceuticals
Series A in 2020
Sonoma Pharmaceuticals, Inc. is a global healthcare company that develops and produces stabilized hypochlorous acid (HOCl) products for diverse applications, including wound care, dermatology, animal health, eye care, and oral care. Based in Woodstock, Georgia, and incorporated in 1999, the company offers over 100 commercially available products worldwide. Its key offerings include Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product for managing dermatoses; Celacyn gel for scar management; and SebuDerm for seborrhea relief. Additionally, Sonoma provides Acuicyn for eye care, Microcyn for expedited wound healing, and various products targeting animal health, such as MicrocynAH and MicrocynVS. The company's focus on addressing unmet medical needs in chronic skin conditions significantly contributes to enhancing patient care while aiming to reduce overall healthcare costs. Sonoma Pharmaceuticals was previously known as Oculus Innovative Sciences, Inc. and rebranded in December 2016.
Sonoma Biotherapeutics
Series A in 2020
Sonoma Biotherapeutics develops adoptive Treg cell therapies aimed at treating autoimmune and degenerative diseases. The company employs advanced genome editing and target-specific cell therapy to create therapeutic solutions that promote self-tolerance and mitigate harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded in 2019 and headquartered in South San Francisco, California, with an additional office in Seattle, Washington, Sonoma Biotherapeutics combines expertise in Treg biology and proprietary methodologies to advance its therapeutic platform, focusing on developing disease-modifying and potentially curative treatments.
Hexagon Bio
Series A in 2020
Hexagon Bio, Inc. is a biotechnology company based in Menlo Park, California, focused on discovering novel drugs for diseases that lack effective treatments. Established in 2016, the company utilizes a data-driven approach that combines genomics, synthetic biology, and computational techniques. By mining genomic data from fungal genomes, Hexagon Bio aims to identify targeted small molecule therapeutics. Its proprietary platform leverages data science to engineer drugs from DNA sequences, enabling the identification of small molecule inhibitors that interact with specific target proteins. This innovative method allows researchers to tap into the global metagenome, facilitating the development of new medicines aimed at improving patient outcomes.
Sirona
Series A in 2020
Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.
Habi
Series A in 2020
Habi is a technology-driven real estate company based in Bogotá, Colombia, that specializes in simplifying the homeownership process for middle-class customers throughout Latin America. Founded in 2019, Habi utilizes a proprietary pricing algorithm and advanced analytical tools to facilitate quicker and more efficient transactions for buying and selling residential properties. By reducing the time required for sales and minimizing risks associated with traditional real estate processes, Habi eliminates the need for intermediaries and empowers clients with essential information. The company's innovative platform aims to enhance the overall experience of homeownership, making it more accessible and streamlined for its users.
High Definition Vehicle Insurance
Series A in 2020
HDVI is a technology-first commercial insurance provider. The company assesses risk using historical and real-time telematics data and provides tools and services that help fleets increase safety, rewards safe driving, and delivers efficient and fair claims processing. HDVI is headquartered in Chicago with additional offices in Greenville, South Carolina; Columbus, Ohio; Portland, Oregon; Dallas and San Francisco. High Definition Vehicle Insurance, Inc. is a licensed property casualty insurance agent with products underwritten by various insurance companies. For more information, visit https://hdvi.com.
Mantra Bio
Series A in 2020
Mantra Bio, Inc. is a biotechnology company focused on developing targeted therapeutics through its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). Founded in 2016 and based in San Francisco, California, the company utilizes its REVEAL platform, which combines computational biology, wet lab techniques, and automation. This innovative approach allows for the design, testing, and optimization of TEVs tailored for specific therapeutic applications across diverse tissue and cellular targets. In addition to its engineering capabilities, Mantra Bio has established a scalable biomanufacturing process to ensure that these novel therapeutics can be produced reproducibly and with high purity, aiming to address intractable diseases effectively.
Beacon
Series A in 2020
Beacon is a digital supply chain and freight platform developed to optimize supply chains with insights and visibility. It offers a freight forwarding service across all modes integrated with its end-to-end visibility platform, connecting each stage of the supply chain to deliver a record of all the information teams need. From bookings to order management, live tracking, and document management, Beacon will move goods with transparency and efficiency, whilst the secure cloud-based software improves accuracy and saves time. The company was founded in 2018 by Fraser Robinson and Dmitri Izmailov and is headquartered in London, England, United Kingdom.
Hearth
Series A in 2020
Hearth is a financial technology platform designed specifically for home improvement contractors. It offers a suite of tools that assist these contractors in managing and growing their businesses. The platform provides essential financial resources, including financing advice, invoicing, payment collections, and insurance products. By enabling contractors to send quotes, contracts, invoices, and financing options from any location, Hearth facilitates a seamless process for closing deals. This comprehensive approach helps contractors streamline operations and improve their overall business efficiency.
Octant Bio
Series A in 2020
Octant Bio is a biotechnology company focused on developing synthetic technology aimed at enhancing health and treating diseases. The company employs a platform that integrates synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells. This advanced technology allows scientists to utilize machine learning techniques to engineer small molecules capable of interacting with multiple receptors, thereby creating new possibilities for the treatment of complex diseases.
Unlearn.AI
Series A in 2020
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
Motherly
Series A in 2020
Motherly, Inc. is a digital platform that focuses on supporting millennial mothers throughout their parenting journey, from conception to college. Established in 2015 and based in Menlo Park, California, the company provides a wealth of resources including articles, videos, and guides that cover diverse topics such as parenting advice, wellness tips, and lifestyle content. The platform offers information on various aspects of motherhood, including child-rearing, self-care, home management, beauty, and career coaching. Additionally, Motherly sells a range of products aimed at mothers, including registry essentials and holiday items. The company, formerly known as Motherly Media, Inc., rebranded in March 2018 to better reflect its mission of redefining motherhood and fostering a community-driven lifestyle brand.
MycoWorks
Series A in 2020
MycoWorks is a biotechnology company focused on developing sustainable, non-plastic and non-animal materials. Utilizing fungal mycelium, the company creates biodegradable alternatives to plastic foams, synthetic textiles, engineered woods, and leather. Their innovative products are designed for various applications, including aerospace, automobiles, apparel, and architectural interiors. By leveraging agricultural byproducts in a carbon-negative process, MycoWorks enables clients to access new types of leather that are grown rapidly and sustainably. This approach not only addresses environmental concerns but also offers practical solutions for industries seeking eco-friendly materials.
Sonoma Biotherapeutics
Series A in 2020
Sonoma Biotherapeutics develops adoptive Treg cell therapies aimed at treating autoimmune and degenerative diseases. The company employs advanced genome editing and target-specific cell therapy to create therapeutic solutions that promote self-tolerance and mitigate harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded in 2019 and headquartered in South San Francisco, California, with an additional office in Seattle, Washington, Sonoma Biotherapeutics combines expertise in Treg biology and proprietary methodologies to advance its therapeutic platform, focusing on developing disease-modifying and potentially curative treatments.
Legalpad
Series A in 2020
Legalpad Inc. is a Seattle-based company founded in 2018 that focuses on streamlining work visa applications for startups and their employees. By combining advanced software with human support, Legalpad simplifies the legal processes associated with O-1, EB-1, H-1B, and B-1 visas. The platform is designed to automate repeatable legal tasks and workflows, thereby enhancing efficiency in the visa application process. Legalpad aims to connect global talent with opportunities, facilitating cross-border employment for individuals and enabling startups to navigate the complexities of hiring international talent.
Xilis
Venture Round in 2019
Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.
Nines
Series A in 2019
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.
Epirus
Venture Round in 2019
Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.
Jacobi
Series A in 2019
Jacobi, Inc. is a technology company that has developed a platform for investment managers to design, analyze, and visualize multi-asset portfolios. Founded in 2014 and headquartered in San Francisco, California, with additional offices in Brisbane, Australia, and London, United Kingdom, Jacobi provides customizable tools that streamline investment processes, allowing users to aggregate portfolios, analyze allocations, and assess associated risks and returns. The platform facilitates deeper engagement between investment managers and clients by transforming complex financial data into intuitive visualizations and interactive dashboards. Additionally, Jacobi offers software development kits to further enhance the capabilities of its platform, promoting better decision-making and improved investment strategies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.